BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17217325)

  • 1. Benfotiamine. Monograph.
    Altern Med Rev; 2006 Sep; 11(3):238-42. PubMed ID: 17217325
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetic neuropathies and angiopathies. Compensating for thiamine deficiency].
    MMW Fortschr Med; 2010 Jun; 152(24):44-5. PubMed ID: 20672589
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic alcohol abuse. Benfotiamine in alcohol damage is a must].
    Ayazpoor U
    MMW Fortschr Med; 2001 Apr; 143(16):53. PubMed ID: 11367995
    [No Abstract]   [Full Text] [Related]  

  • 4. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
    Stracke H; Gaus W; Achenbach U; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):600-5. PubMed ID: 18473286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic and therapeutic application of thiamine (vitamin B1)--a new point of view].
    Małecka SA; Poprawski K; Bilski B
    Wiad Lek; 2006; 59(5-6):383-7. PubMed ID: 17017487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral benfotiamine therapy. Thus you protect the nerves of diabetic patients].
    MMW Fortschr Med; 2004 Jan; 146(5):52-3. PubMed ID: 15035429
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months.
    Stirban OA; Zeller-Stefan H; Schumacher J; Gaus W; Ziegler D; Schuerholz T; Pop-Busui R
    J Diabetes Complications; 2020 Dec; 34(12):107757. PubMed ID: 33069584
    [No Abstract]   [Full Text] [Related]  

  • 8. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).
    Haupt E; Ledermann H; Köpcke W
    Int J Clin Pharmacol Ther; 2005 Feb; 43(2):71-7. PubMed ID: 15726875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effectiveness of the neurotropic agents: benfotiamin combinations].
    Internist (Berl); 1995 Feb; 36(2 Suppl Wirksamkei):1-4. PubMed ID: 9403088
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy.
    Winkler G; Pál B; Nagybéganyi E; Ory I; Porochnavec M; Kempler P
    Arzneimittelforschung; 1999 Mar; 49(3):220-4. PubMed ID: 10219465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bendotiamine efficacy in alcoholic polyneuropathy therapy].
    Anisimova EI; Danilov AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(12):32-6. PubMed ID: 11811123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of neuropathies].
    Kempler P
    Orv Hetil; 2004 May; 145(21):1145-7. PubMed ID: 15206196
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of diabetic angiopathies].
    Fövényi J
    Orv Hetil; 2004 Mar; 145(12):634-7. PubMed ID: 15119119
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic neuropathy.
    Gominak S; Parry GJ
    Adv Neurol; 2002; 88():99-109. PubMed ID: 11908239
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of diabetes-related chronic kidney disease.
    Reddy N
    Nephrol News Issues; 2011 Jun; 25(7):20, 22. PubMed ID: 21736131
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of benfothiamine in the therapy of diabetic polyneuropathy].
    Nikolić A; Kacar A; Lavrnić D; Basta I; Apostolski S
    Srp Arh Celok Lek; 2009; 137(11-12):594-600. PubMed ID: 20069914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
    Inkster ME; Cotter MA; Cameron NE
    Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of benfotiamine and its molecular targets.
    Raj V; Ojha S; Howarth FC; Belur PD; Subramanya SB
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3261-3273. PubMed ID: 29863274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the transdermal delivery of benfotiamine.
    Zhu Z; Varadi G; Carter SG
    Acta Diabetol; 2016 Apr; 53(2):317-22. PubMed ID: 26141141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress on the drug therapy for diabetic microangiopathies: AGE inhibitors].
    Yamagishi S; Imaizumi T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():136-8. PubMed ID: 15999696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.